Pharma City 2 SRL

4.7 FTE

Pharma City 2 reported total assets of €1.72m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 4.7 full-time equivalents.

Company number (CBE) 1003.993.550 · VAT BE1003993550
1000 Brussels
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 28 Dec 2023 (≈ 3 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pharma City 2 shows with a free account.

See the score
Profile
SRL Micro · 4.7 FTE since 2023
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result182,873 €
Equity400,627 €
Cash282,439 €
EBITDA349,415 €
Total assets€1.72m
Headcount (avg FTE)4.7
The line marks its sector median: 37.8% (349 companies).

Accounts of the company itself (not consolidated).

The full file covers 2 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pharma City 2's annual accounts

20252024
Net result182,873 €
Equity400,627 €
Cash282,439 €
EBITDA349,415 €
Total assets€1.72m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Aug 2026
  • Year ended 31 Dec 2024filed on 26 May 2025

Pharma City 2's financial analysis

Management and control of Pharma City 2

1 active director(s) in the register.

Pharma City 2's shareholders and holdings →

Pharma City 2's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
1003.993.550
VAT number
BE1003993550
Peppol
Registered · 0208:1003993550 · as of 10 Nov 2026
Legal form
SRL
Incorporated
28 Dec 2023
Registered office
1000 Brussels
Size
Micro · 4.7 FTE
Latest accounts
2025 · filed on 31 Aug 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Pharma City 2 (SRL) has been based in Brussels since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 182,873 € and equity of 400,627 €; its revenue is not published. With 4.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 23.2%, below the median of its sector (37.8%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Pharma City 2

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pharma City 2

What is the revenue of Pharma City 2?

Pharma City 2 files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Pharma City 2?

In Belgium, the VAT number is the company number prefixed with BE: BE1003993550 for Pharma City 2, if the company is VAT-registered. Its company number (CBE) is 1003.993.550.

Where is the registered office of Pharma City 2?

According to the CBE register, the registered office of Pharma City 2 is in 1000 Brussels.

What is the equity of Pharma City 2?

At the close of the 2025 financial year, the equity of Pharma City 2 amounts to 400,627 €, a solvency of 23.2% of total assets.

How many people work at Pharma City 2?

4.7 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Pharma City 2?

The register lists 1 active mandates at Pharma City 2. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Pharma City 2

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 18 Sep 2026

No credit card, no commitment.

What each plan unlocks →